DaVita
DVA • NYSE
DaVita is a medical - care facilities company in the healthcare sector trading on NYSE, led by CEO Javier J. Rodriguez, with a market cap of $10.3B.
CEOJavier J. Rodriguez
Next Earnings
Upcoming earnings announcement for DaVita
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$2.36
Revenue Estimate
$3.3B
Earnings History
Past 12 earnings reports for DaVita
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Q4 2025 | $3.40Est: $3.21 | +5.9% | $3.6BEst: $3.5B | +3.0% | — |
| Oct 29, 2025 | Q3 2025 | $2.51Est: $3.22 | -22.0% | $3.4BEst: $3.4B | -0.0% |  10-Q |
| Aug 5, 2025 | Q2 2025 | $2.95Est: $2.73 | +8.1% | $3.4BEst: $3.4B | +0.8% | 10-Q |
| May 12, 2025 | Q1 2025 | $2.00Est: $2.02 | -1.0% | $3.2BEst: $3.2B | +0.4% | 10-Q |
| Feb 13, 2025 | Q4 2024 | $2.24Est: $2.14 | +4.7% | $3.3BEst: $3.3B | +0.9% | 10-K |
| Oct 29, 2024 | Q3 2024 | $2.59Est: $2.73 | -5.1% | $3.3BEst: $3.3B | +0.4% | 10-Q |
| Aug 6, 2024 | Q2 2024 | $2.59Est: $2.54 | +2.0% | $3.2BEst: $3.2B | +1.2% | 10-Q |
| May 2, 2024 | Q1 2024 | $2.38Est: $1.95 | +22.1% | $3.1BEst: $3.0B | +1.4% | 10-Q |
| Feb 13, 2024 | Q4 2023 | $1.87Est: $1.59 | +17.6% | $3.1BEst: $3.0B | +4.5% | 10-K |
| Nov 7, 2023 | Q3 2023 | $2.85Est: $2.02 | +41.1% | $3.1BEst: $3.0B | +3.3% | — |
| Aug 3, 2023 | Q2 2023 | $2.08Est: $1.66 | +25.3% | $3.0BEst: $2.9B | +2.0% | 10-Q |
| May 8, 2023 | Q1 2023 | $1.58Est: $1.14 | +38.6% | $2.9BEst: $2.8B | +1.2% | 10-Q |